IGC Pharma (IGC) vs Rockwell Medical (RMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
IGC Pharma (IGC) has outperformed Rockwell Medical (RMTI) over the past year, losing 33.4% versus a loss of 34.8%. Over five years, IGC leads with a -80.8% price change compared with -88.0% for RMTI. Rockwell Medical is the larger company by market cap ($31.8 million vs $28.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IGC | RMTI |
|---|---|---|
| Share price | $0.2799 | $7.89 |
| Market cap | $28.94M | $31.80M |
| 1-day change | -1.75% | -1.62% |
| YTD return | -0.04% | -4.94% |
| 1-year return | -33.36% | -34.79% |
| 5-year return | -80.83% | -88.05% |
| Forward P/E | — | 112.71 |
| EPS (TTM) | $-0.07 | $-1.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.45 | $12.90 |
| 52-week low | $0.24 | $4.89 |
| Distance from 52-week high | -37.80% | -38.84% |
| Analyst consensus | none | none |
| Avg. price target upside | +2043.62% | +153.49% |
| Average volume | 701.31K | 26.30K |
| Shares outstanding | 103.38M | 4.03M |
| Employees | 70 | 157 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IGC Pharma
IGC stock →IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's.
Health Care · Biotechnology: Pharmaceutical Preparations · 70 employees
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees
IGC vs RMTI FAQ
Which is bigger, IGC Pharma or Rockwell Medical?
Rockwell Medical (RMTI) is larger, with a market capitalization of $31.80M compared with $28.94M for IGC Pharma (IGC).
Which stock has performed better over the past year, IGC or RMTI?
IGC returned -33.36% over the past 12 months, compared with -34.79% for RMTI (price return, excluding dividends). Past performance does not predict future results.
Are IGC Pharma and Rockwell Medical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.